Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma"

Ann Surg Oncol. 2020 Dec;27(Suppl 3):954-955. doi: 10.1245/s10434-020-09183-1. Epub 2020 Oct 4.

Authors

Vincenza Granata¹, Roberta Fusco², Raffaele Palaia¹, Andrea Belli¹, Antonella Petrillo¹, Francesco Izzo¹

Affiliations

¹ Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Naples, Italy.
² Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Naples, Italy. r.fusco@igeamedical.com.

PMID: 33011913
DOI: 10.1245/s10434-020-09183-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma* / drug therapy
Animals
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Disease Models, Animal
Electrochemotherapy*
Electroporation
Fluorouracil
Humans
Irinotecan
Leucovorin
Mice
Oxaliplatin
Pancreatic Neoplasms* / drug therapy

Substances

folfirinox
Oxaliplatin
Irinotecan
Leucovorin
Fluorouracil